ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Peter Jones Is Interim director of USC’s Norris; NIAMS Funds Skin Disease Corse At Yale, Texas

January 1, 1993

MD Anderson President Ronald DePinho: “Some of the Feedback was Humbling”

March 29, 2013

Obituary: Michale Keeling, of M.D. Anderson.

January 2, 2004

Gonzalez-Angulo To Serve 10 Years In Poisoning Case

October 3, 2014

Northwestern Repays Government $3 Million To Settle Claims Over Use Of NCI Grants; Researcher Bennett Now Faces Feds Alone

August 9, 2013

FDA Approves Implant For Breast Reconstruction

July 26, 2013